scholarly journals Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

2021 ◽  
Author(s):  
Keyword(s):  
Clinical Practice ◽  
Liver Disease ◽  
Fatty Liver ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Fatty Liver Disease ◽  
Italian Society ◽  
Alcoholic Fatty Liver ◽  
Italian Association ◽  
Alcoholic Fatty Liver Disease

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline

2018 ◽  
Vol 41 (5) ◽  
pp. 328-349
Author(s):  
Rocío Aller ◽  
Conrado Fernández-Rodríguez ◽  
Oreste lo Iacono ◽  
Rafael Bañares ◽  
Javier Abad ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Liver Disease ◽  
Fatty Liver ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Fatty Liver Disease ◽  
Document Management ◽  
Alcoholic Fatty Liver ◽  
Consensus Document ◽  
Alcoholic Fatty Liver Disease

Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice

2012 ◽  
Vol 6 (5) ◽  
pp. 381-394 ◽  
Author(s):  
Jérôme Boursier ◽  
Marie-Christine Rousselet ◽  
Christophe Aubé ◽  
Paul Calès
Keyword(s):  
Clinical Practice ◽  
Liver Disease ◽  
Liver Fibrosis ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

scholarly journals Non-alcoholic fatty liver disease: current aspects of diagnosis in real clinical practice

2021 ◽  
Vol 2 (4) ◽  
pp. 40-50
Author(s):  
Dmitry I. Trukhan ◽  
Keyword(s):  
Clinical Practice ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Metabolic Diseases ◽  
Diagnostic Algorithm ◽  
Malignant Neoplasms ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease ◽  
Real Clinical Practice

In the diagnosis and subsequent supervision of patients with non-alcoholic fatty liver disease (NAFLD) and obesity in real clinical practice, the role and importance of the doctor of first contact (therapist and general practitioner) increases. Non-alcoholic fatty liver disease is currently considered as the hepatic component of metabolic syndrome. A diagnostic algorithm for NAFLD at the stage of primary health care is presented. The most difficult question at 2–4 levels of the diagnostic algorithm is the differential diagnosis between NAFLD and alcoholic liver disease. During a pandemic of a novel coronavirus infection (COVID-19), patients with NAFLD or NASH, as a rule, have concomitant metabolic diseases such as diabetes mellitus, arterial hypertension and obesity, and also have to take a large number of potentially hepatotoxic drugs, it is advisable to classify them as elevated risk of infection with SARS-CoV-2, and the severe course of this infection. This allows us to consider NAFLD as dangerous in terms of the severe course of COVID-19, as viral hepatitis, autoimmune hepatitis and liver fibrosis / cirrhosis. It is known that NAFLD is an independent predictor of not only high cardiovascular risks, but also hepatocellular carcinoma and malignant neoplasms of various localization, as well as a number of other comorbid conditions. The review concludes with a clinical observation illustrating the difficulty of early diagnosis of intrahepatic cholangiocarcinoma in a patient with NAFLD and other metabolic risk factors.

Sign in / Sign up

Export Citation Format

Share Document